Navigation Links
OncoSec Medical Announces $7.2 Million Public Offering
Date:12/13/2012

SEC's website at www.sec.gov or by request at Dawson James Securities, Inc. by e-mailing placements@djsiny.com.

This announcement is neither an offer to sell nor a solicitation of an offer to buy any of OncoSec's common stock or warrants. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

About OncoSec Medical Inc.

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's cu
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its ... highly sophisticated agro-breeding solutions for plant breeders and researchers, ... board of directors appointed chemistry and pharmaceutical industry expert ... of the board. From 1975 to 2012, ...
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... With its unique, non-hierarchical, team-based culture, global manufacturing company W. ... on FORTUNE magazine,s annual list of the 100 Best Companies ... 31. This marks Gore,s 14th consecutive appearance on the list, ... in every edition of the rankings. (Photo: ...
... 2011 Ascension Orthopedics, Inc., a leader ... MOVEMENT™ Great Toe Implant System to include a total ... allows surgeons the intra-operative choice to perform hemi-resurfacing for ...   Available in four sizes, the MOVEMENT ...
Cached Medicine Technology:W. L. Gore & Associates Continues Its Tradition as One of Nation's Best Workplaces 2Ascension Orthopedics Introduces True Modularity With MOVEMENTâ„¢ Great Toe System 2
(Date:4/17/2014)... (April 16, 2014) The cause of neuronal death ... study proposes that neurons may be mistaken for foreign ... similar to the way autoimmune diseases like type I ... cells. The study was published April 16, 2014, in ... and likely controversial, idea in Parkinson,s disease; but if ...
(Date:4/17/2014)... Medicine (BUSM) have discovered that the anti-seizure drug ... The findings, reported in the American Journal ... to more effective treatments for alcoholism. , Excessive ... causes of illness and death in the U.S. ... the productivity of workers and necessitating huge health ...
(Date:4/17/2014)... the potential to ward off depression among retirees, particularly ... online in The Journals of Gerontology, Series ... the article " Internet Use and Depression Among Retired ... ," the authors report that Internet use reduced the ... their study sample. , Late-life depression affects between ...
(Date:4/17/2014)... days to find a colored ribbon representing a disease. A ... what color ribbon does one think of with lung cancer?, ... many suffering from the disease, black may be the only ... of lung cancer patients, primarily smokers between the ages of ... the stigma often felt by these patients, the emotional toll ...
(Date:4/17/2014)... than 40 years away from a food shortage that ... to a top scientist at the U.S. Agency for ... food production will be limited on a global scale ... Dr. Fred Davies, senior science advisor for the agency,s ... politically destabilizing by 2050 as energy issues are today.", ...
Breaking Medicine News(10 mins):Health News:Is Parkinson's an autoimmune disease? 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Internet use may cut retirees' depression 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Food shortages could be most critical world issue by mid-century 2
... Recent Purchase for Installation in United Kingdom, ... ARAY ), a global leader in the field ... Hospital,Corporation of America (HCA), has purchased its seventh ... Clinic in London,England. This marks HCA,s first non-U.S. ...
... of heart disease, study finds , , THURSDAY, Oct. 4 (HealthDay ... abnormality in the heart,s left main artery should take special ... brothers and sisters of someone with such problems are 2.5 ... compared to the siblings of patients with heart disease not ...
... SOUTH SAN FRANCISCO, Oct 4 Anesiva, Inc.,(Nasdaq: ... host a briefing for the,investment community to review ... hydrochloride monohydrate) powder,intradermal injection system. The briefing will ... to 1:30 p.m. Eastern Time in New York ...
... alleviate fears associated ... with common diabetes complication, ALEXANDRIA, Va., Oct. 4 ... trick-or-treating ghosts and,goblins. But for some, there is something that ... dysfunction is a diabetes complication for both men and women.,According ...
... WASHINGTON, Oct. 3 Congressman Chaka Fattah,(D- PA) ... Child Health,Insurance Program. "The numbers just don,t ... $190,billion for the war, but he won,t support ... poor children. Quality health insurance is vital to ...
... 3 Could you actually be allergic to,work? If ... workplace,you may suffer from occupational asthma. This disorder is ... gases, dusts or other potentially harmful substances while "on ... & Immunology,(AAAAI). "We estimate that about 15%, or ...
Cached Medicine News:Health News:Hospital Corporation of America Purchases Seventh CyberKnife(R) System 2Health News:Hospital Corporation of America Purchases Seventh CyberKnife(R) System 3Health News:Hospital Corporation of America Purchases Seventh CyberKnife(R) System 4Health News:Cardiac Artery Trouble Boosts Family Heart Risk 2Health News:Cardiac Artery Trouble Boosts Family Heart Risk 3Health News:Anesiva to Unveil Zingo(TM) Commercialization Plans 2Health News:Diabetes in the Bedroom: Scarier than Halloween? 2Health News:AAAAI: Asthma on the Job 2Health News:AAAAI: Asthma on the Job 3
... The StatSpin CytoFuge 2 is the ... It's simple, understandable controls and new snap-seal ... before. Samples are processed quickly, silently and ... safety cabinet. Results are consistent: easy to ...
... The CritSpin whisper quiet, compact system ... clinic anywhere fast, accurate and cost effective ... Digital Reader, the CritSpin System offers a ... spin, complete cell packing - Meets NCCLS ...
Unique "finger-stick" collection system utilizes a capillary tube for easy blood drawing; no "scooping" necessary. After draining into a microtube, blood is centrifuged and serum or plasma is easily ...
... swinging bucket rotor. ,The MicroPrep 2 is ... swinging bucket rotor and optional fixed angle ... variety of clinical, biomedical, industrial, and biotechnology ... a "swinging bucket centrifuge in a small, ...
Medicine Products: